Trial of Combination of Ixazomib and Lenalidomide and Dexamethasone in Smoldering Multiple Myeloma
Clinical trial NCT02916771 · COMPLETED
Trial details
- NCT number
- NCT02916771
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2025-01-08
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.